Neuropeptide
VIP
VIP is vasoactive intestinal peptide, a neuropeptide whose name does not restrict its research to the intestine. Animal and neuronal models have examined its participation in temporal coordination within the suprachiasmatic nucleus.
This is a research reference, not a product offered in the Asciende catalog. Published studies do not establish the identity, purity or availability of a commercial preparation.
Local signaling and experimental context
Record where and how the measurement was made. Presence of a peptide in a system does not establish that a commercial preparation reproduces that system.
- Does the work study an isolated molecule, endogenous secretion or a preparation containing several components?
- Are tissue, species and response measurement specified?
- Does the interpretation distinguish signal detection from demonstration of its function in that model?
Mechanism described in the literature
In mice and neuronal cultures, VIP–VPAC2 signaling participates in both cellular rhythms and their synchronization. Having rhythmic cells and having coordinated cells are different properties of a network.
Other names in the literature
- Vasoactive intestinal peptide
- Vasoactive intestinal polypeptide
Lighting changes what the model reveals
The 2003 study observed animals under different lighting conditions. Some alterations became apparent in constant darkness even when patterns under light-dark cycles looked close to controls. The experimental environment can conceal or reveal circadian-system differences (PMID 12855416).
A genetic deletion that also affects PHI
That model lost both VIP and the related peptide PHI. Its results should therefore not be described as a VIP-only intervention. Naming the complete model makes the causal limitation explicit: a change after eliminating two products cannot be assigned entirely to one.
Rhythmicity and synchrony are studied separately
The 2005 work added VPAC2-deficient comparisons and neuronal recordings. A receptor agonist restored rhythmic properties in a VIP-deficient preparation but not a receptor-deficient one. The comparator was an experimental agonist rather than VIP, helping locate pathway dependence (PMID 15750589).
Questions and answers
Does normal activity under light-dark cycles rule out alterations?
No. The 2003 study showed that other lighting conditions revealed differences.
Did every cited experiment use VIP as its material?
No. They include genetic deletions and a VPAC2 agonist; each intervention must be identified.
Sources
- Disrupted circadian rhythms in VIP- and PHI-deficient mice. — Am J Physiol Regul Integr Comp Physiol, 2003
- Disrupted circadian rhythms in VIP- and PHI-deficient mice.
- Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons. — Nat Neurosci, 2005
- Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons.